GEAHF yields 7.00% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, GEAHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GEAHF + PFE for your $10,000?
Great Eagle Holdings Limited, an investment holding company, invests in, develops, and manages residential, office, retail, and hotel properties in Asia, North America, Australasia, and Europe. The company operates through Hotel Operation, Property Investment, Property Development, Other Operations, Champion REIT, Langham, and US Real Estate Fund segments. The company engages in leasing furnished apartments and properties; and flexible workspace, asset management, hotel accommodation, food and banquet, and restaurant operations. It also owns and operates three hotels under The Langham, Cordis, and Eaton brand names. In addition, the company offers property management services, including security services, staff services, maintenance and repairs, consultancy services, as well as property maintenance, leasing, and agency services. Further, it trades in building materials; invests in securities; manages real estate investment trust, computer system solutions, project advisory, treasury management, investment, and investment fund management services, as well as real estate agency services; procurement and financing, and general trading services; and issues medium term notes. The company was founded in 1963 and is headquartered in Wanchai, Hong Kong.
Full GEAHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.